Randomisation in the SYMPHONY trial
- PMID: 11081555
- DOI: 10.1016/S0140-6736(05)73268-2
Randomisation in the SYMPHONY trial
Comment on
-
Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial. The SYMPHONY Investigators. Sibrafiban versus Aspirin to Yield Maximum Protection from Ischemic Heart Events Post-acute Coronary Syndromes.Lancet. 2000 Jan 29;355(9201):337-45. Lancet. 2000. PMID: 10665552 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources